# Breath of Life Pharma, Ltd. — Form D

Breath of Life Pharma, Ltd. of REVADIM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-15. The offering totals $12.0M, of which $9.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-06-15
- Form: D
- Accession: 0001742928-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $12.0M
- Amount sold: $9.7M
- Remaining: $2.3M
- Minimum investment: $10K
- Investors: 21
- Date of first sale: 2018-05-21
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-314690

## Issuer

- Name: Breath of Life Pharma, Ltd.
- CIK: 0001742928
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Incorporated: 2017
- Address: INDUSTRIAL AREA, REVADIM, L3, 7982000
- Phone: 2129810355

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Tamir Gedo | Director | Revadim, Y8 |
| Tamir Gedo | Executive Officer | Revadim, Y8 |

## More

- [CIK 1742928 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1742928&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001742928-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.